Cargando…
Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome
Breast cancer can rarely present with or be preceded by paraneoplastic syndromes such as opsoclonus-myoclonus syndrome (OMS). OMS is a rare neurological syndrome that commonly presents with symptoms of rapid, chaotic eye movements (opsoclonus), jerking involuntary muscle movements (myoclonus) and is...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416628/ https://www.ncbi.nlm.nih.gov/pubmed/36046059 http://dx.doi.org/10.7759/cureus.28417 |
_version_ | 1784776525012271104 |
---|---|
author | Soares, Ryan Mittapalli, Amrutha Ramakrishnan, Manju Farooq, Umar |
author_facet | Soares, Ryan Mittapalli, Amrutha Ramakrishnan, Manju Farooq, Umar |
author_sort | Soares, Ryan |
collection | PubMed |
description | Breast cancer can rarely present with or be preceded by paraneoplastic syndromes such as opsoclonus-myoclonus syndrome (OMS). OMS is a rare neurological syndrome that commonly presents with symptoms of rapid, chaotic eye movements (opsoclonus), jerking involuntary muscle movements (myoclonus) and is frequently associated with ataxia. We describe a case of a woman in her early 50s who presented to the emergency room (ER) with vertigo, jerking movements, loss of fine motor skills and gait abnormalities. She was initially thought to have likely vestibular neuritis and was treated symptomatically and discharged home. However, the symptoms persisted and she presented once again to the ER, at which time she also incidentally discovered a lump in her breast. This led to her being investigated more extensively leading to a diagnosis of underlying primary breast cancer. Based on her neurological clinical findings, she was diagnosed with onconeural antibody negative OMS. Treatment of her underlying malignancy led to a significant improvement in her symptoms. Paraneoplastic neurological syndromes (PNSs) are an important differential diagnosis to consider in patients presenting with persistent, treatment-resistant and non-specific neurological symptoms. Any suspicion of the same should prompt a search for an underlying malignancy that could greatly influence patient outcomes. |
format | Online Article Text |
id | pubmed-9416628 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-94166282022-08-30 Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome Soares, Ryan Mittapalli, Amrutha Ramakrishnan, Manju Farooq, Umar Cureus Internal Medicine Breast cancer can rarely present with or be preceded by paraneoplastic syndromes such as opsoclonus-myoclonus syndrome (OMS). OMS is a rare neurological syndrome that commonly presents with symptoms of rapid, chaotic eye movements (opsoclonus), jerking involuntary muscle movements (myoclonus) and is frequently associated with ataxia. We describe a case of a woman in her early 50s who presented to the emergency room (ER) with vertigo, jerking movements, loss of fine motor skills and gait abnormalities. She was initially thought to have likely vestibular neuritis and was treated symptomatically and discharged home. However, the symptoms persisted and she presented once again to the ER, at which time she also incidentally discovered a lump in her breast. This led to her being investigated more extensively leading to a diagnosis of underlying primary breast cancer. Based on her neurological clinical findings, she was diagnosed with onconeural antibody negative OMS. Treatment of her underlying malignancy led to a significant improvement in her symptoms. Paraneoplastic neurological syndromes (PNSs) are an important differential diagnosis to consider in patients presenting with persistent, treatment-resistant and non-specific neurological symptoms. Any suspicion of the same should prompt a search for an underlying malignancy that could greatly influence patient outcomes. Cureus 2022-08-25 /pmc/articles/PMC9416628/ /pubmed/36046059 http://dx.doi.org/10.7759/cureus.28417 Text en Copyright © 2022, Soares et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Soares, Ryan Mittapalli, Amrutha Ramakrishnan, Manju Farooq, Umar Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome |
title | Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome |
title_full | Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome |
title_fullStr | Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome |
title_full_unstemmed | Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome |
title_short | Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome |
title_sort | breast cancer presenting as onconeural antibody negative opsoclonus-myoclonus syndrome |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416628/ https://www.ncbi.nlm.nih.gov/pubmed/36046059 http://dx.doi.org/10.7759/cureus.28417 |
work_keys_str_mv | AT soaresryan breastcancerpresentingasonconeuralantibodynegativeopsoclonusmyoclonussyndrome AT mittapalliamrutha breastcancerpresentingasonconeuralantibodynegativeopsoclonusmyoclonussyndrome AT ramakrishnanmanju breastcancerpresentingasonconeuralantibodynegativeopsoclonusmyoclonussyndrome AT farooqumar breastcancerpresentingasonconeuralantibodynegativeopsoclonusmyoclonussyndrome |